7 Day Trial
ALL ACCESS PASS
Plus Therapeutics Stock Forecast
Is Plus Therapeutics Stock Undervalued?
The current Plus Therapeutics [PSTV] share price is $0.47. The Score for PSTV is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- PSTV is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Plus Therapeutics Stock Go Up Next Year?
Plus Therapeutics Stock Rating
Plus Therapeutics Stock Price History
Is Plus Therapeutics stock public?
Yes, Plus Therapeutics is a publicly traded company.
What is the Plus Therapeutics stock quote today?
The Plus Therapeutics stock price is 0.47 USD today.
How to buy Plus Therapeutics stock online?
You can buy Plus Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Plus Therapeutics Earnings
Plus Therapeutics Forecast Revenue Growth
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.30 per share, and an increase next year of $0.06 per share.
* Plus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.